The following are the recommendations of various equity research houses and investment consultants. These stocks make a good investment bet with a time horizon of one to two years.

These 20 stocks should be kept on your radar for investment purpose. These stocks have been recommended by various stock research analysts and institutions.

1. ASHOK LEYLAND : The earnings estimates for FY12 and FY13 are Rs2.5 and Rs3.1 respectively. Our FY13 earnings estimate is 11.2% higher than the consensus estimate of Rs2.7.We have a 'BUY' recommendation on the stock with a target price of Rs38, which discounts FY13E earnings by 12.5x.
2. ASHOKA BUILDCON : Our FY12 and FY13 earnings estimates are Rs19.4 and Rs25.9, 15.8% and 14.4% lower than consensus estimates respectively. We expect top-line growth of 29.3% and 30.1% to Rs16.8bn and Rs21.9bn in FY12E and FY13E vs. consensus forecasts of 28.2% and 32.5% to Rs16.7bn and Rs22.1bn, respectively. We value BOT (on a DCF basis) at FY12E and FY13E equity multiples of 1.6x and 1.1x, respectively. Our SOTP-based target price is Rs321, where BOT is valued at Rs198 and EPC at Rs122 (8x FY12E earnings). The stock offers an upside potential of 75.2% at our SOTP-based target price of Rs321 vs. consensus target of Rs293.
3. BAJAJ AUTO : Our FY12 and FY13 earnings estimates are Rs107.5 and Rs123.3, respectively. We have a 'BUY' recommendation on the stock with a target price of Rs1,850 discounting FY13E earnings at 15x. Our FY13 earnings estimate is 3.3% higher than the consensus estimate of Rs119.4.
4. BANK OF BARODA :Morgan Stanley has upgraded Bank of Baroda to EQUALWEIGHT with a target of Rs 615. It feels the bank is relatively better positioned against peers from a balance sheet perspective.  Its ability to withstand a more intense asset quality cycle is relatively better than other public sector banks such as SBI, PNB and BOI.
5. CESC : Our FY12 & FY13 PAT estimates are in line with consensus. We value various projects - both existing and future - on FCFE basis to arrive at a target price of Rs346 (terminal growth rate 3% and cost of equity 15%).
6. HEROHONDA : UBS has upgraded Hero Moto to BUY with a target of Rs 2,250. It believes rural demand remains a significant driver for two-wheelers. Also the margin outlook for the company remains strong with low valuations pricing in the threat of increased competition.
7. HCL TECH : Our revenue estimates marginally differ from consensus by 1% and (0.7%) for FY12 and FY13 respectively. While EBITDA margin and EPS estimates for FY12 are higher than consensus by 58 bps and 7% respectively; for FY13 EBITDA margin and EPS estimates lag the consensus by 46bps and 3% respectively.
8. HSIL : Our earnings estimates (EPS) for FY12 and FY13 are Rs20.0 and Rs27.4, respectively. Our FY12 earnings estimate is 12% higher than the consensus estimate of Rs17.8. We have a 'BUY' recommendation on the stock with a target price of Rs270, which discounts FY12e earnings by 13.5x.
9. INDUSIND : Goldman Sachs has reiterated its conviction BUY on IndusInd Bank with a target of Rs 350. After the strong Q3 numbers, they believe the bank's growth momentum will remain healthy despite tough macros. It expects EPS growth of over 23% in the next three years driven by branch expansion.
10. INFOSYS : Our revenue estimates are inline with consensus for FY12 and marginally lower than consensus for FY13 by 1.3%. EBITDA margin estimates are higher by 112bps for FY12 and 80 bps for FY13. While our EPS estimate is 1.8% higher than consensus EPS for FY12, it lags the consensus by 1.2% for FY13.
11. IRB INFRA : Our FY12 and FY13 earnings estimates are Rs14.5 and Rs12.5, 0.9% and 20.9% lower than consensus estimates respectively. We expect top-line growth of 28.2% and 22.3% to Rs31.3bn and Rs38.2bn in FY12E and FY13E vs. consensus forecasts of 29.6% and 24.3% to Rs31.6bn and Rs39.2bn, respectively.
12. JAGRAN PRAKASHAN (JPL): Our FY13 revenue estimate is 5% below consensus. However, our FY13 EPS estimate of Rs8 is in-line with consensus. We have a 'BUY' recommendation on the stock with a target price of Rs148 (18.6xFY13E EPS).
13. JYOTHY LABORATORIES : Our estimates for FY13 are am